Conformal has completed a Series D extension financing round, securing $32m to support its clinical trial of the CLAAS ...

HeartFlow’s $364m initial public offering (IPO) signals market validation for the use artificial intelligence (AI) in a ...

The SEMR JV between Interventional Systems and HICREN has obtained approval for the Intelligent SpinePecker spinal surgical ...

SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...

Drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity Partners.

Singapore-based HistoIndex has launched a new artificial intelligence (AI)-based laboratory developed test (LDT) in the US for measuring fibrosis in patients with metabolic dysfunction-associated ...

The US Food and Drug Administration (FDA) has granted approval for Thermo Fisher Scientific’s Oncomine Dx Target Test as a treatment for non-small cell lung cancer (NSCLC). The test serves as a ...

SetPoint Medical has secured $140m through private financing, earmarked for the commercial rollout of the SetPoint System.

On 8 August, the US Food and Drug Administration (FDA) granted accelerated approval to Hernexeos (zongertinib) - a human epidermal growth factor receptor 2 (HER2) selective tyrosine kinase inhibitor - ...

US Food and Drug Administration (FDA) commissioner Martin Makary has announced that the IV fluid shortage for sodium chloride 0.9% injection products is now over after nearly a year of disruption.

This year's Alzheimer's Association International Conference, which took place in Toronto, Canada from July 27-31 featured a range of data readouts from companies developing in vitro diagnostics (IVD) ...

Dana-Farber Cancer Institute has unveiled a new blood test that could change the way multiple myeloma (MM) and its precursor conditions.